Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
about
Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies.The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
P2860
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@ast
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@en
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@nl
type
label
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@ast
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@en
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@nl
prefLabel
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@ast
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@en
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@nl
P2860
P356
P1433
P1476
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
@en
P2093
Ana-Iris Schiefer
Melanie R Hassler
P2860
P304
P356
10.2217/EPI.13.39
P407
P50
P577
2013-08-01T00:00:00Z